Visual Outcomes, Endothelial Loss, and Complications Following Iris-Claw Intraocular Lens Implantation and Trocar-Assisted Sutureless Scleral Fixation of Intraocular Lenses
Beyoglu Eye Journal · 2023 · 253-259
DOI: 10.14744/bej.2023.30085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Beyoglu Eye Journal, 2023. Verfasst von Ebubekir Durmus und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Istanbul Medeniyet University, İstanbul, Türkiye. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Istanbul Medeniyet University, İstanbul, Türkiye.
- Department of Ophthalmology, Goztepe Prof. Dr. Suleyman Yalçin City Hospital, İstanbul, Türkiye.
- Department of Ophthalmology, Kadikoy Diabetes Hospital, İstanbul, Türkiye.
Zitieren
APA
Durmus, E., Aykut, V., Hepokur, M., Sali, F., Sanisoglu, H. A., Oguz, H., & Esen, F. (2023). Visual Outcomes, Endothelial Loss, and Complications Following Iris-Claw Intraocular Lens Implantation and Trocar-Assisted Sutureless Scleral Fixation of Intraocular Lenses. Beyoglu Eye Journal, 253-259. https://doi.org/10.14744/bej.2023.30085
Vancouver
Durmus E, Aykut V, Hepokur M, Sali F, Sanisoglu HA, Oguz H, et al. Visual Outcomes, Endothelial Loss, and Complications Following Iris-Claw Intraocular Lens Implantation and Trocar-Assisted Sutureless Scleral Fixation of Intraocular Lenses. Beyoglu Eye Journal. 2023:253-259. doi:10.14744/bej.2023.30085
BibTeX
@article{Durmus2023,
author = {Durmus, Ebubekir and Aykut, Veysel and Hepokur, Mustafa and Sali, Fatma and Sanisoglu, Huseyin Avni and Oguz, Halit and Esen, Fehim},
title = {Visual Outcomes, Endothelial Loss, and Complications Following Iris-Claw Intraocular Lens Implantation and Trocar-Assisted Sutureless Scleral Fixation of Intraocular Lenses},
journal = {Beyoglu Eye Journal},
year = {2023},
pages = {253--259},
doi = {10.14744/bej.2023.30085}
}
EUVIMED